QI
PDLI

Qtron Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Qtron Investments’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-82,464
Closed -$307K – 271
2019
Q1 		$307K Hold
82,464
– – 0.28% 111
2018
Q4 		$239K Buy
+82,464
New +$227K 0.18% 141

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Qtron Investments's PDLI Position: Q2 2019 in Review

Qtron Investments sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 82,464 shares — an estimated $307K sold.

Qtron Investments first reported a position in PDLI in Q4 2018 and held it in 2 quarters. The position peaked at $307K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Qtron Investments reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Qtron Investments sold 82,464 PDL BioPharma, Inc. shares in Q2 2019, an estimated $307K.
  • Qtron Investments first reported a position in PDL BioPharma, Inc. in Q4 2018 and held it in 2 quarters.
  • Qtron Investments's PDL BioPharma, Inc. position peaked at $307K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Qtron Investments's 13F filing for Q2 2019, filed 13 Aug 2019.